Status:
COMPLETED
OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
40+ years
Brief Summary
Descriptive prospective non-interventional multicenter study based on newly collected data of Idiopathic Pulmonary Fibrosis patients followed-up for one year in secondary care settings (Pulmonology Se...
Eligibility Criteria
Inclusion
- Female and male patients ≥ 40 years of age
- Patients diagnosed with Idiopathic Pulmonary Fibrosis (IPF) according to last ATS/ERS/JRS/ALAT IPF guideline for diagnosis and management consensus
- Written informed consent prior to participation
Exclusion
- Inability for the patient to understand or complete the written Inform Consent or patients questionnaires or to understand Spanish
- Current participation in any clinical trial
- Patients for whom further follow-up is not possible at the enrolling site
Key Trial Info
Start Date :
November 29 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 16 2019
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT03386994
Start Date
November 29 2017
End Date
September 16 2019
Last Update
November 9 2020
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Universitario de Alicante
Alicante, Spain, 03010
2
Hospital Infanta Cristina
Badajoz, Spain, 06080
3
Hospital Universitario Cruces
Barakaldo (Vizcaya), Spain, 48903
4
H. del Mar
Barcelona, Spain, 8003